Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

10.5%

2 terminated/withdrawn out of 19 trials

Success Rate

89.5%

+3.0% vs industry average

Late-Stage Pipeline

5%

1 trials in Phase 3/4

Results Transparency

0%

0 of 17 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
11(91.7%)
Phase 4
1(8.3%)
12Total
N/A(11)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (19)

Showing 19 of 19 trials
NCT04997057Not ApplicableCompleted

A Multistrain Probiotic in Patients With Irritable Bowel Syndrome With Predominant Constipation

Role: collaborator

NCT04812418Not ApplicableCompleted

Evaluation of a Combination of Plants in Anxiety-related Sleep Disorders: Randomized Trial Versus Placebo

Role: lead

NCT04987164Completed

Incidence of Cystitis in Women Consuming a Mixture of Cranberry, Cinnamon, Probiotics

Role: collaborator

NCT05213910Not ApplicableCompleted

Study of a Management Strategy of Functional Bowel Disordes Related to Irritable Bowel Syndrome (IBS) With a Mixture of 8 Microbiotic Strains

Role: lead

NCT03554187Not ApplicableCompleted

Efficacy of Supplementation With Probiotics as Adjuvant to Mechanical Treatment in Chronic Periodontitis

Role: lead

NCT01530685Not ApplicableCompleted

Gycabiane and Glycemic Control of Prediabetic Subjects

Role: lead

NCT00915629Not ApplicableTerminated

Prevention of Recurrent Vulvovaginal Candidiasis With Lactibiane Candisis 5M®

Role: lead

NCT04628819Not ApplicableTerminated

Effect and Tolerability of Lactobacillus Rhamnosus GG LA801 for the Preventive Nutritional Care of Nosocomial Diarrhea in Children

Role: lead

NCT01529359Not ApplicableCompleted

Irritable Bowel Syndrome and Lactibiane Tolerance

Role: lead

NCT04574141Not ApplicableCompleted

Kinetic of Melatonin Subsequent to the Consumption of Melatonin-rich Food Supplements

Role: lead

NCT02728063Not ApplicableCompleted

Lactibiane Tolérance® in Individuals Suffering From Irritable Bowel Syndrome With Diarrheal Predominance

Role: lead

NCT04728269Not ApplicableCompleted

Exploratory Study on Lactibiane Topic AD on Skin Flora and Barrier Reinforcement in Mild to Moderate Atopic Dermatitis

Role: lead

NCT04324658Completed

Effect and Tolerance of a Probiotic-based Medical Device Administered to Patients With Irritable Bowel Syndrome

Role: lead

NCT02977936Completed

Management of Joint Pain Associated With Osteoarthritis of the Knee With Association of Plant Extracts.

Role: lead

NCT02967796Completed

Strategy of Micronutrient Management in Parturient and Layered Women With a Dietary Supplement Rich in Porphyra HSP®

Role: lead

NCT02981238Completed

Phytotherapy Strategy for Sleep Disorders Related to Anxiety With a Combination of Eschscholtzia and Valerian Extracts

Role: lead

NCT02981225Completed

Management Strategy for Mild to Moderate Major Depression: Combination of Rhodiola and Saffron Extracts.

Role: lead

NCT02901756Completed

A Combination of Coenzyme Q10, Feverfew and Magnesium for Migraine Prophylaxis : a Prospective Observational Study

Role: lead

NCT00449917Phase 4Completed

"Visiobiane Anti-age" Effects on Vision Parameters

Role: lead

All 19 trials loaded